FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

oseltamivir phosphate
(Oseltamivir phosphate)
Ajanta Pharma USA Inc.
Usage: Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for up to 48 hours, and for prophylaxis in patients 1 year and older. It's not a substitute for annual vaccination.
oseltamivir phosphate
(Oseltamivir)
AvKARE
Usage: Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older symptomatic for no more than 48 hours, and for prophylaxis in those aged 1 year and older. It is not a substitute for annual influenza vaccination.
oseltamivir phosphate
(Oseltamivir Phosphate)
AvKARE
Usage: Oseltamivir phosphate for oral suspension is indicated for treating uncomplicated influenza A and B in patients 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual influenza vaccination.
oseltamivir phosphate
(Oseltamivir phosphate)
MSN LABORATORIES PRIVATE LIMITED
Usage: Oseltamivir phosphate capsules are indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. They are also used for the prophylaxis of influenza in individuals 1 year and older. Annual vaccination is recommended.
oseltamivir phosphate
(OSELTAMIVIR PHOSPHATE)
Aurobindo Pharma Limited
Usage: Oseltamivir phosphate oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for vaccination and may have effectiveness limitations.
tamiflu
(oseltamivir phosphate)
Genentech, Inc.
Usage: TAMIFLU is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in those 1 year and older. It is not a substitute for vaccination and has limitations regarding resistance and specific patient populations.

Neuraminidase Inhibitor class drugs

oseltamivir phosphate

oseltamivir phosphate

oseltamivir phosphate

oseltamivir phosphate

oseltamivir phosphate

tamiflu